4.5 Article

Elastin-like recombinamers as substrates for retinal pigment epithelial cell growth

Journal

JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
Volume 97A, Issue 3, Pages 243-250

Publisher

WILEY
DOI: 10.1002/jbm.a.33050

Keywords

regenerative medicine; biomaterial; RPE cells; AMD; elastin-like recombinamers

Funding

  1. Castilla and Leon Regenerative Medicine and Cell Therapy Network Center
  2. CIBER-BBN
  3. AECI (Part of the Spanish Ministry of Foreign Affairs)
  4. Junta de Castilla-Leon
  5. National Plan of I+D+I
  6. Spanish Institute of Health Carlos III (ISCIII)-Subdireccion General de Evaluacion y Fomento de la Investigacion (MICNN) [PS09/00938]

Ask authors/readers for more resources

The aim of this study is to investigate the use of elastin-like recombinamers (ELRs) as a substrate that can maintain the growth, phenotype, and functional characteristics of retinal pigment epithelial (RPE) cells efficiently and as a suitable carrier for the transplantation of autologous RPE cells for treatment of age-related macular degeneration (AMD). ELR films containing a bioactive sequence, RGD (ELR-RGD), and one with no specific sequence (ELR-IK) as control, were obtained by solvent-casting onto glass and subsequent cross-linking. ARPE19 cells were seeded on sterilized ELR films as well as on the control surfaces. Cells were analysed after 4, 24, 72, and 120 h to study cell adhesion, proliferation, cell viability, morphology, and specificity by staining with Trypan blue, DAPI, Rhodamin-Phalloidin and RPE65, ZO-1 antibodies and observing under fluorescence as well as electron microscope. ARPE19 cells seeded on both ELR films and controls were 100% viable and maintained their morphology and set of characteristics at the different time points studied. Cell proliferation on ELR-RGD was significantly higher than that found on ELR-IK at all time points, although it was less than the growth rate on polystyrene. ARPE19 cells grow well on ELR-RGD maintaining their phenotype. These results should be extended to further studies with fresh human RPE cells and in vivo studies to determine whether this ELR-RGD matrix could be used as a Bruch's membrane prosthesis and carrier for transplantation of RPE cells in patients suffering with AMD. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 97A: 243-250, 2011.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available